UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
12b-25
NOTIFICATION
OF LATE FILING
(Check One):
o Form
10-K o Form
20-F o Form 11-K
x Form
10-Q o Form
10-D o Form
N-SAR o Form N-CSR
For
Period Ended: March 31, 2009
o Transition Report on
Form 10-K
o Transition Report on
Form 20-F
o Transition Report on
Form 11-K
o Transition Report on
Form 10-Q
o Transition Report on
Form N-SAR
For the transition period ended:
______________________________
Nothing in this form shall be construed
to imply that the Commission has verified any information contained
herein.
If the notification relates to a
portion of the filing checked above, identify the item(s) to which the
notification relates:
PART
I
REGISTRANT
INFORMATION
Full Name
of Registrant: Oragenics,
Inc.
Former
Name if Applicable: N/A
Address
of Principal Executive Office (Street and
Number): 13700 Progress
Blvd.
City,
State and Zip Code: Alachua, Florida
32615
PART
II
RULE
12b-25(b) AND (c)
If the subject report could not be
filed without unreasonable effort or expense and the registrant seeks relief
pursuant to Rule 12b-25(b), the following should be completed. (Check
box if appropriate.)
|
|
(a)
|
The
reasons described in reasonable detail in Part III of this form could not
be eliminated without unreasonable effort or
expense;
|
|
|
(b)
|
The
subject annual report, semi-annual report, transition report on Form 10-K,
Form 20-F, Form 11-K, Form N-SAR, or Form N-CSR, or portion thereof, will
be filed on or before the fifteenth calendar day following the prescribed
due date; or the subject quarterly report or transition report on Form
10-Q, or portion thereof, will be filed on or before the fifth calendar
day following the prescribed due date;
and
|
|
|
(c)
|
The
accountant’s statement or other exhibit required by Rule 12b-25(c) has
been attached if applicable.
|
PART
III
NARRATIVE
State
below in reasonable detail the reasons why the Forms 10-K, 20-F, 11-K, 10-Q,
10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be
filed within the prescribed time period.
The Company’s
Form 10-Q for the quarter ended March 31, 2009 could not be completed by the
Company without unreasonable effort or expense due to the Company’s
significantly limited financial resources at the present time. While the Company
expects its Form 10-Q to be filed within the next five days, there can be no
assurance that it will be able to do so.
PART
IV
OTHER
INFORMATION
(1) Name
and telephone number of person to contact in regard to this
notification
|
David
Hirsch
|
|
(386)
418-4018
|
|
(Name)
|
|
(Area Code)
(Telephone Number)
|
(2) Have
all other periodic reports required under Section 13 or 15(d) of the Securities
Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during
the preceding 12 months or for such shorter period that the registrant was
required to file such report(s) been filed? If answer is no, identify
report(s).
x Yes o No
(3) Is
it anticipated that any significant change in results of operations from the
corresponding period for the last fiscal year will be reflected by the earnings
statements to be included in the subject report or portion thereof?
o Yes x No
If so, attach an explanation of the
anticipated change, both narratively and quantitatively, and, if appropriate,
state the reasons why a reasonable estimate of the results cannot be
made.
Oragenics,
Inc.
(Name of
Registrant as Specified in Charter)
Has
caused this notification to be signed on its behalf by the undersigned thereunto
duly authorized.
|
Date: May
15, 2009
|
|
/s/
David Hirsch |
|
| |
|
By: David
Hirsch |
|
| |
|
Title: Acting
Chief Executive Officer |
|